{
  "name": "Published hazard ratios beside time-scale and follow-up context: antiviral trials and the Women's Health Initiative",
  "description": "Compiled from two peer-reviewed methodology papers: Spruance et al. 2004 (hazard ratio versus median ratio in three antiviral trials) and Hernán 2010 (period-specific and overall hazard ratios for coronary heart disease in the Women's Health Initiative combined hormone therapy trial). Shows that an HR can differ from time-based effects and from itself across follow-up windows.",
  "page": "https://casrai.org/guides/how-to-interpret-a-hazard-ratio",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-18T01:16:40Z",
  "temporalCoverage": "2004/2010",
  "spatialCoverage": null,
  "columns": [
    {
      "name": "Example",
      "unit": "",
      "description": ""
    },
    {
      "name": "Window or setting",
      "unit": "",
      "description": ""
    },
    {
      "name": "Hazard ratio",
      "unit": "",
      "description": "As reported by the source"
    },
    {
      "name": "Median ratio (placebo/treatment)",
      "unit": "",
      "description": "Only reported for the antiviral trials"
    },
    {
      "name": "Source",
      "unit": "",
      "description": ""
    }
  ],
  "rows": [
    {
      "Example": "Valaciclovir 500 mg, recurrent genital herpes episodes",
      "Window or setting": "Whole trial",
      "Hazard ratio": 1.9,
      "Median ratio (placebo/treatment)": 1.5,
      "Source": "Spruance 2004"
    },
    {
      "Example": "Famciclovir, postherpetic neuralgia resolution",
      "Window or setting": "Whole trial",
      "Hazard ratio": 1.9,
      "Median ratio (placebo/treatment)": 2,
      "Source": "Spruance 2004"
    },
    {
      "Example": "Acyclovir, herpes zoster pain duration",
      "Window or setting": "Whole trial",
      "Hazard ratio": 1.5,
      "Median ratio (placebo/treatment)": 3.1,
      "Source": "Spruance 2004"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Year 1",
      "Hazard ratio": 1.81,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Year 2",
      "Hazard ratio": 1.34,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Year 3",
      "Hazard ratio": 1.27,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Year 4",
      "Hazard ratio": 1.25,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Year 5",
      "Hazard ratio": 1.45,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Year 6 or later",
      "Hazard ratio": 0.7,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    },
    {
      "Example": "WHI combined hormone therapy, coronary heart disease",
      "Window or setting": "Overall (mean follow-up 5.2 years)",
      "Hazard ratio": 1.24,
      "Median ratio (placebo/treatment)": "not reported",
      "Source": "Hernán 2010"
    }
  ],
  "sources": [
    {
      "title": "Spruance et al., Hazard ratio in clinical trials, Antimicrob Agents Chemother 2004",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC478551",
      "accessed": "2026-11-17"
    },
    {
      "title": "Hernán, The hazards of hazard ratios, Epidemiology 2010",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3653612/",
      "accessed": "2026-11-17"
    }
  ]
}